Skip to main navigation Skip to search Skip to main content

Tumor characteristics associated with benefit from pembrolizumab in advanced non–small cell lung cancer

  • Siwen Hu-Lieskovan
  • , Aaron Lisberg
  • , Jesse M. Zaretsky
  • , Tristan R. Grogan
  • , Hira Rizvi
  • , Daniel K. Wells
  • , James Carroll
  • , Amy Cummings
  • , John Madrigal
  • , Benjamin Jones
  • , Jacklin Gukasyan
  • , I. Peter Shintaku
  • , Dennis Slamon
  • , Steven Dubinett
  • , Jonathan W. Goldman
  • , David Elashoff
  • , Matthew D. Hellmann
  • , Antoni Ribas
  • , Edward B. Garon

Research output: Contribution to journal › Article › peer-review

60   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Tumor characteristics associated with benefit from pembrolizumab in advanced non–small cell lung cancer'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology

Neuroscience